- Report
- April 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,465GBP
- Report
- April 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,465GBP
- Report
- April 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,465GBP
- Report
- January 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,465GBP
- Report
- January 2025
- 175 Pages
Global
From €3998EUR$4,490USD£3,465GBP
- Report
- July 2025
- 371 Pages
Global
From €5209EUR$5,850USD£4,515GBP
- Report
- July 2025
- 280 Pages
Global
From €5209EUR$5,850USD£4,515GBP
- Report
- April 2025
- 182 Pages
Global
From €3406EUR$3,825USD£2,952GBP
€4007EUR$4,500USD£3,473GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1336EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£965GBP
- Report
- February 2025
- 185 Pages
Global
From €3406EUR$3,825USD£2,952GBP
€4007EUR$4,500USD£3,473GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1781EUR$2,000USD£1,544GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1336EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1113EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1336EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1781EUR$2,000USD£1,544GBP
- Report
- June 2025
- 150 Pages
Global
From €2403EUR$2,699USD£2,083GBP
- Report
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,153GBP
- Report
- May 2025
- 134 Pages
Global
From €13353EUR$14,995USD£11,573GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more